Australia markets open in 4 hours 26 minutes

BCAL Diagnostics Limited (BDX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0930+0.0010 (+1.09%)
At close: 01:29PM AEST
Full screen
Previous close0.0920
Open0.0930
Bid0.0940 x N/A
Ask0.0960 x N/A
Day's range0.0930 - 0.0930
52-week range0.0700 - 0.2100
Volume101,849
Avg. volume240,961
Market cap23.463M
Beta (5Y monthly)0.27
PE ratio (TTM)N/A
EPS (TTM)-0.0200
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    BCAL Findings Presented at 2023 ASCO Annual Meeting

    BCAL Diagnostics Limited (ASX:BDX) (BCAL or Company) today announced the presentation of data demonstrating the potential for detection of early breast cancer using a plasma lipidomic biomarker signature. BCAL is developing a non-invasive blood screening test that is intended to be used alongside breast cancer screening methods, such as mammography. The poster, "Lipidomic Signature From Plasma to Detect Localised Breast Cancer," was presented at the 2023 ASCO Annual Meeting (Chicago, 2-6 June 20